Evidence map›Paper›PMID 39452248›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Investigation into the Effectiveness of an Herbal Combination (Angocin

Nina Kassner, Meinolf Wonnemann, Yvonne Ziegler, Rainer Stange, Karel Kostev

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nina KassnerRepha GmbH Biologische Arzneimittel, 30855 Langenhagen, Germany.ORCID 0009-0007-9464-3718
Meinolf WonnemannRepha GmbH Biologische Arzneimittel, 30855 Langenhagen, Germany.ORCID 0000-0002-3200-6867
Yvonne ZieglerRepha GmbH Biologische Arzneimittel, 30855 Langenhagen, Germany.ORCID 0009-0003-7262-4517
Rainer StangeDepartment for Internal and Integrative Medicine, Immanuel Hospital, 10117 Berlin, Germany.
Karel KostevIQVIA Epidemiology, 60549 Frankfurt, Germany.ORCID 0000-0002-2124-7227

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe goal of this study was to evaluate whether the medical recommendation of Angocin

methodsThis study included patients in general practices in Germany with a first documented diagnosis of acute bronchitis between 2005 and 2022 (index date) and a prescription of Angocin

resultsAfter a 1:5 propensity score matching, 598 Angocin

conclusionsConsidering the limitations of the study, the results shed light on the sustaining effectiveness of Angocin

Indexed as

acute bronchitisAngocin® Anti-Infekt Nantibioticschronic bronchitisphytotherapysick leave

Identifiers

PMID39452248
PMCPMC11505283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.